Most of the evidence for these important functions relies on mouse or rat studies. Therefore, the present study was designed to investigate the presence of lipofibroblasts in a variety of early postnatal and adult mammalian species (including humans) to evaluate the ability to generalize functions of this cell type for other species. For this purpose, lung samples from 14 adult mammalian species as well as from postnatal mice, rats, and humans were investigated using light and electron microscopic stereology to obtain the volume fraction and the total volume of lipid bodies. In adult animals, lipid bodies were observed only, but not in all rodents. In all other species, no lipofibroblasts were observed. In rodents, lipid body volume scaled with body mass with an exponent b ϭ 0.73 in the power law equation. Lipid bodies were not observed in postnatal human lungs but showed a characteristic postnatal increase in mice and rats and persisted at a lower level in the adult animals. Among 14 mammalian species, lipofibroblasts were only observed in rodents. The great increase in lipid body volume during early postnatal development of the mouse lung confirms the special role of lipofibroblasts during rodent lung development. It is evident that the cellular functions of pulmonary lipofibroblasts cannot be transferred easily from rodents to other species, in particular humans. interstitial cell; lipid body; pulmonary lipofibroblast; electron microscopy; design-based stereology THE ALVEOLAR SEPTA OF THE MAMMALIAN LUNG consist of a continuous epithelial layer (in most species two different cell types) surrounding the capillary bed and a slender connective tissue compartment that conveys the elastic properties and provides stability to the delicate structures of the gas-exchange region. The connective tissue fibers are produced by fibroblasts that may contain contractile actin filaments or lipid bodies. In the latter case, these cells are also referred to as lipid interstitial cells or lipofibroblasts (3, 28, 34) . The morphology of lipofibroblasts is similar to that of the hepatic stellate cell (46).
THE ALVEOLAR SEPTA OF THE MAMMALIAN LUNG consist of a continuous epithelial layer (in most species two different cell types) surrounding the capillary bed and a slender connective tissue compartment that conveys the elastic properties and provides stability to the delicate structures of the gas-exchange region. The connective tissue fibers are produced by fibroblasts that may contain contractile actin filaments or lipid bodies. In the latter case, these cells are also referred to as lipid interstitial cells or lipofibroblasts (3, 28, 34) . The morphology of lipofibroblasts is similar to that of the hepatic stellate cell (46) .
Lipofibroblasts are characterized by the presence of large cytoplasmic lipid inclusions without a limiting biomembrane (17, 50) . Such organelles can be found regularly in several types of cell and appear to be inducible in nearly all cell types (33) and to be important for the synthesis of eicosanoids (61, 62) . Under normal conditions, in the alveolar region, they occur frequently in lipofibroblasts and rarely in other cell types, such as alveolar epithelial type II (AE2) cells (8, 36) . The latter are known to synthesize, store, secrete, and partly recycle pulmonary surfactant (10) . AE2 cells contain the lamellar bodies as the storage organelle of lung surfactant. As lung surfactant is a mixture of ϳ90% lipids, mainly saturated phosphatidylcholine, and 10% proteins, several studies have linked the fibroblast-associated lipid bodies with the synthesis of surfactant by AE2 cells (25, 44, 51) .
Comparative analysis of the available literature shows that the occurrence of lipid bodies in fibroblasts and AE2 cells in mammalian lungs depends on the species and the developmental stage. For example, lipofibroblasts were described in rodent (23) and in human lungs (40) . In the rat lung, lipofibroblasts are frequent in postnatal lungs and seem to undergo apoptosis during the first 30 days of postnatal development, thus contributing to the thinning of alveolar septa (1) . The ability to store retinoic acid within the lipid bodies as well as the crucial role of retinoic acid for lung development has established an important role for this cell type in development of the normal rat lung (7, 47) . Besides lipofibroblasts, myofibroblasts have also been attributed a significant involvement in normal lung development (56) . In addition, exogenous application of retinoic acid to elastase-induced emphysematous rat lungs has been shown to reverse the emphysematous alterations at least in part (27) . Despite various studies confirming a beneficial effect of retinoic acid in emphysema models (19, 27) , other studies failed to show emphysema reversal (13, 18) or highlighted an irregular repair process (45) . In the light of the above mentioned studies on retinoic acid and lung development, it may be hypothesized that lipofibroblasts contributed to the effects of retinoic acid on emphysema pathology. As such, lipofibroblasts have been attributed important functions in the lung, namely the contribution to surfactant synthesis, retinoic acid metabolism, and lung development. With the knowledge that differences in lipofibroblasts exist between mammalian species, the contribution of these cells to any of these important functions may vary among species as well. However, a basic, systematic study analyzing the content of lipid bodies associated with fibroblasts and AE2 cells is not available so far.
Therefore, in the present study, we investigated the presence of lipid bodies in fibroblasts and AE2 cells in 14 mammalian species by transmission electron microscopy (TEM) and quantified them by design-based stereology. In addition, the lipid body content was analyzed during postnatal development in the mouse, the rat, and the human lung.
MATERIALS AND METHODS
Origin of animal and human lungs. Most of the samples for the interspecies comparison were taken from the archive of the Institute of Anatomy at the University of Bern, Switzerland: Etruscan shrew, mouse, rat, rabbit, dog, goat, human, camel, giraffe, steer, and horse. Details on body mass, lung volume, and the number of animals used are given in Table 1 . Additional samples of the gas-exchange region of the lungs of lama, chinchilla, and crabeater seal were kindly provided by Prof. Dr. H. Bartels (Hannover Medical School). All of these lungs were previously investigated in the context of other research projects not related to this study ( Table 1 ). The human lung material was first analyzed in the study by Gehr et al. (14) , and the use of the lungs was according to the bioethical regulations of the University of Bern at that time. The subjects from which the human lungs were obtained died, between 1971 and 1976, from serious cerebral injury or from cardiac arrest (14) . In compliance with current standards for human subjects, the lungs were deidentified by assigned numbers. Five lungs of the originally reported ones were arbitrarily picked for this and a previous study (65) .
Postnatal rat lungs were taken from a previous study on the surfactant system of the postnatal lung (43) . Early postnatal and infant human lungs were also taken from the archive of the Institute of Anatomy at the University of Bern. They were previously published by Zeltner et al. (67) and Zeltner and Burri (66) , and the relevant case histories are presented in these papers. In compliance with current standards for human subjects, the lungs were deidentified by assigned numbers. All of the original studies underwent a bioethical evaluation, and the use of the lungs was according to the bioethical regulations of the University of Bern at that time. The postnatal mouse lungs were newly prepared for this study, and the death for organ taking of the mice by exsanguination under isoflurane anesthesia was indicated to the respective authorities. Details on age, body mass, lung volume, and number of postnatal mice and rats are given in Table 2 .
Lung preparation (except seal, lama, and chinchilla). All animals were deeply anesthetized before lung fixation. The thoracic cavity was opened to induce lung collapse, and the lungs were fixed by airway instillation of 2.5% glutarladehyde buffered with potassium-phosphate (interspecies comparison) or 1.5% glutaraldehyde, 1.5% paraformaldehyde in 0.15 M Hepes buffer (postnatal mouse lungs). Depending on the point of reference, the hydrostatic pressure was 20 -30 cm H 2O. The human lungs were taken after clinical verification of death and also fixed by airway instillation post mortem. The volume of all lungs was measured by Archimedes' principle (42) . For the interspecies comparison, samples were taken from the parenchymal region of the lung randomly and embedded in epoxy resin according to standard procedures. The sampling procedure was a stratified sampling to avoid taking samples from nonparenchymal regions where the structures of interest are not present (for a detailed description see Ref 59) . Lung volume was multiplied by 0.85 to obtain the volume of the parenchyma, as the volume fraction of the parenchyma shows relatively little species variations and varies between 80 and 90% (38) . Postnatal mouse lungs were subjected to systematic uniform random sampling, including nonparenchymal structures, and the samples were either embedded in glycol methacrylate (Technovit 7100; Heraeus Kulzer, Wehrheim, Germany) for light microscopy (LM) or in epoxy resin for TEM according to standard procedures (reviewed in Ref. 31 ). The volume fraction of the parenchyma of the postnatal mouse and rat lungs was estimated by stereology (see below).
The samples of postnatal rat lungs were fixed by perfusion fixation in 1.5% glutaraldehyde, 1.5% paraformaldehyde in 0.15 M Hepes buffer; those of seal, lama, and chinchilla were fixed by immersion of small pieces in phosphate-buffered 3.5% glutaraldehyde solution. Although the exact embedding procedure differed from the one described above with respect to incubation times and composition of incubation media, all samples underwent poststaining in osmium tetroxide, en bloc staining with uranyl acetate, and dehydration before embedding in epoxy resin.
Stereology. From the epoxy resin-embedded tissue blocks (n ϭ 3-4 for each animal), semithin and ultrathin sections were cut with an ultramicrotome and stained with toluidine blue or uranyl acetate and lead citrate, respectively. From the samples embedded in glycol methacrylate, 1.5-m-thick sections were generated and stained with toluidine blue. All LM analyses were carried out with a Leica DM 6000B microscope equipped with a digital camera and a computer with the newCAST software (Visiopharm, Horsholm, Denmark). TEM analyses on one ultrathin section from each tissue block were performed with a Morgagni 268 microscope (FEI, Eindhoven, Netherlands). Fields of view for stereological analyses were gathered by systematic uniform random sampling. Due to the larger size of alveoli in larger-sized animals, and therefore the greater probability of fields of view without alveolar septa, we adjusted the sampling fraction to make sure that an approximately equal number of test fields containing septal tissue was investigated for each animal. All stereological procedures comply with recently published guidelines (20, 32, 35) .
At the LM level, the volume fraction of parenchyma in the postnatal mouse and rat lung was estimated by the point-counting method at an objective lens magnification of ϫ10 using a grid consisting of 25 points (58). The volume fraction of parenchyma was calculated by VV(par/lung) ϭ P(par)/P(lung), where P(par) is the sum of points hitting lung parenchyma and P(lung) is the sum of points hitting all lung structures including parenchyma. The volume fraction was then multiplied by the lung volume to obtain the absolute volume of the parenchyma. The semithin sections from all postnatal stages and all species were used to estimate the volume fraction of alveolar septa related to the parenchyma by point counting [V V(sept/par)].
At the TEM level, fields of view containing profiles of alveolar septa or AE2 cells were taken and subjected to point counting using a fine lattice with 225 points and a coarse lattice of four points (where each point of the coarse lattice represents 56.25 points of the fine lattice). Fine points hitting lipid bodies within alveolar interstitial fibroblasts and coarse points hitting alveolar septum were counted to calculate the volume fraction of interstitial fibroblast lipid bodies within alveolar septa [V V(li/sept)]. Similarly, the volume fraction of lipid bodies was estimated in AE2 cells. This multicascade approach was used to finally calculate the total volume of interstitial fibroblast lipid bodies by V(li, lung) ϭ V(par, lung) * V V(sept/par) * VV(li/ sept).
Additionally, some semithin sections from postnatal rat and human lung were also stained by Sudan Black to visualize lipid bodies at LM level. Correlative electron microscopic images from subsequent ultrathin sections were taken to identify the Sudan Black staining as lipid bodies.
Statistics. The allometric relationship was expressed in the form of y ϭ ax b using the module curve fit in the SPSS software, and regression analysis was performed to obtain the regression coefficient R 2 .
RESULTS

Adult mammalian lung.
Lipid bodies associated with fibroblasts were observed in mouse, rat, and rabbit lungs (Fig. 1) . Despite careful analysis, we did not find lipofibroblasts in the lungs of any other species. The volume density of the lipid bodies related to the volume of the septa was highest in the mouse (Table 3 , Fig. 2 ). In the interspecies comparison, the total volume of fibroblast-associated lipid bodies, therefore, did not rise in direct proportion with body mass, which was reflected by the exponent b (0.73) in the power law equation when the total volume was scaled against body mass. If lipid body volume was directly proportional, we would expect b ϭ 1.
In all species, very few lipid bodies were observed in AE2 cells either as true, separate lipid body, or as an intermediate form between a lipid body and a lamellar body. In these The overall composition of alveolar septa for the compartments alveolar epithelial cells, endothelial cells, capillary lumen, interstitial cells, and extracellular matrix is shown in Table 4 . Despite differences of the volume fraction of the capillary lumen, probably caused by the fixation, the overall composition of the alveolar septa was similar in all species. The volume fraction of interstitial cells ranged between 2% and 7%, and the total volume rose from 0.3 l in the Etruscan shrew to 207 ml in the cattle. In line with the larger alveoli in larger-sized species, the volume density of septa declines with rising body mass.
Postnatal mouse, rat, and human lungs. Lipofibroblasts were observed in postnatal rodent lungs (Figs. 3, 4 , and 5) but not in the postnatal human lungs. The volume density of fibroblast-associated lipid bodies (related to the septal volume) rose steeply both in mouse and rat lungs during the first 14 days and declined until 42 days. However, the time course and the slope were not identical in mouse and rat, indicating species differences. Similarly, the total volume of lipid bodies increased faster than body mass in both species during the first 14 days. After that, the total volume either stayed constant (rat) until 42 days or even declined (mouse) ( Table 5 , Figs. 6 and 7) .
Similar to the adult lungs, the amount of lipid bodies within AE2 cells was very low in the rodent and human lungs. Due to the above mentioned imprecision of the quantitative data, we only screened for obvious differences between the age groups but did not find any evidence for age-specific changes in the amount of AE2 cell-associated lipid bodies.
DISCUSSION
Lipofibroblasts are thought to be a special cell type in the alveolar septum, which has the characteristics of fibroblasts and contains a high amount of nonmembrane-bound lipid bodies. They have been described in mouse, rat, hamster, and human lungs (23, 40) . This cell type has gained considerable interest in recent years for two reasons. 1) Evidence was provided for a role of lipofibroblasts in surfactant production. The proposed mechanism included the release of prostaglandin E2 from AE2 cells, which in turn stimulates the transfer of lipid from fibroblasts to AE2 cells, a phenomenon potentiated by dexamethasone (51, 52) . 2) More recently, the lipofibroblast Values in parentheses are SD. VV, volume density; V, total volume; sep, alveolar septum; par, lung parenchyma; EpC, alveolar epithelial cells; EnC, endothelium of septal capillaries; lu, lumen of septal capillaries; IC, interstitial cell; ECM, extracellular matrix.
has been identified as a potential stem cell niche in the lung, and lineage-tracing experiments have shown that fibroblast growth factor 10-expressing cells are precursors of lipofibroblasts and that there is no significant transdifferentiation from lipo-to myofibroblasts (9) , which was suggested by in vitro experiments upon nicotine exposure (39) . This and other studies suggest that lipofibroblasts may be crucially involved in the regeneration of lung tissue. For example, in vitro lipofibroblasts were shown to repair elastic fibers after treatment of an elastic fiber matrix with elastase (30) . Furthermore, vitamin A is stored in lipofibroblasts (37, 48) and increases the lipid content of lipofibroblasts in the adult hamster lung (48) . As the treatment of emphysematous mice with vitamin A/retinoids resulted in reverse remodeling and the alleviation of the emphysema phenotype (27, 19) , considerable hopes for the translation of this treatment to patients with emphysema were raised although the regenerative potential of vitamin A/retinoic acid seems to depend on the type of emphysema mouse model or the pharmacogenetics of the mouse strains being used (13, 18) . Further support for this rationale came from studies substantiating a role of vitamin A/retinoic acid and the retinoic acid receptor for normal human lung development (2, 12) and the inverse relationship between serum vitamin A levels and lung function in patients with chronic obstructive pulmonary disease (29) . As a consequence, clinical trials have been performed showing, on the one hand, that treatment of humans with all-trans-retinoic acid is feasible and safe (26, 41) and, on the other hand, however, that a ␥-selective retinoid receptor agonist failed to induce a regenerative effect in patients with emphysema (49) . In light of these considerations, it appears reasonable to address the presence of lipofibroblasts in the early postnatal and adult mammalian lung, in particular in rodent and human lungs. In the present study, the lungs of 14 adult mammalian species were analyzed with respect to the presence of lipofibroblasts in the alveolar septa by TEM. This approach was ideal to identify the lipid bodies based on their characteristic morphology and to attribute observed lipid bodies to a certain cell type. Thus it does not depend on the specificity of antibodies or dyes. A limitation of this approach clearly is the small amount of tissue under investigation. The absence of a particular structure in the analyzed material does not necessarily guarantee that it is absent in other parts of the lung as well. Therefore, we investigated ultrathin sections from three to four randomly sampled tissue blocks per lung. A limitation attributable to the randomization is the possibility that an inhomogeneous distribution with a higher frequency in subpleural regions potentially provides a higher chance of sampling subpleural regions in smaller than in larger lungs.
In the adult lung, lipid bodies were mainly found in fibroblasts of mice, rats, and rabbits but not in the fibroblasts of any other species. Scaling of the lipid body volume to body mass (only in those species containing fibroblastassociated lipid bodies) showed that the volume of lipid bodies is not proportional to body mass but rather seems to depend on the species. Furthermore, a very low amount of lipid bodies was observed in AE2 cells with only one exception, the dog, which had a considerably higher amount of AE2 cell-associated lipid bodies than the other species. Very rarely, intracellular lipid bodies were observed within the alveolar interstitium and were mainly attributed to leukocytes. These analyses confirm the well-established presence of lipofibroblasts in the rodent lung (23, 53) but contrast with a study demonstrating lipofibroblasts in the human lung (40) . One of the reasons for this discrepancy may be the different analytical approach; Rehan and coworkers (40) used a combination of immunohistochemistry, RT-PCR, Western blot, and triglyceride uptake to identify and characterize the fibroblasts in cultured human fibroblasts. The cells may have changed their phenotype because of the culture conditions and may be an artifact of the cell culture. However, the authors also presented Oil red O staining and immunohistochemistry for adipocyte-differentiation-related protein to identify lipofibroblasts in human lung tissue sections. In particular, the Oil red O staining clearly showed the presence of lipid body containing cells in the alveolar region of the human lung, and the authors interpreted them as lipofibroblasts. It remains unclear why we were not able to confirm these findings. As mentioned above, our TEM approach has the advantage that lipid body-containing cells can be further characterized based on their morphology and their localization, i.e., whether they are truly interstitial cells. It may be that the cells stained by Oil red O are other cells containing lipid bodies, such as neutrophils or alveolar macrophages, as this method is frequently used to characterize alveolar macrophages and neutrophils from bronchoalveolar lavage (55) . On the other hand, the small amount of tissue that constitutes an electron microscopic ultrathin section may prevent the observation of rare events. The fact that we did observe lipofibroblasts in the lungs of rodents but not in any other species suggests that, if lipofibroblasts are present in nonrodent mammalian lungs, then they have to be very rare and cannot play the same crucial role in pulmonary physiology of most mammalian species, including humans, as has been proposed for rodents.
In postnatal development of the rat lung, interstitial fibroblasts were described in detail by Vaccaro and Brody (53) . These authors showed that, at birth, the predominant interstitial fibroblast is characterized by large intracytoplasmic lipid accumulations. Later on, these lipofibroblasts were mainly observed at the base of newly forming septa, whereas a second type of fibroblast occurs at the tip of the newly forming septa and appears to be responsible for the synthesis of elastin (4, 53) . At 28 days after birth, the amount of lipofibroblasts in the rat lung has decreased, but the cell type is still present. The time course of the postnatal development of lipofibroblasts was studied in various rodent species showing first a postnatal increase and subsequently a decline in the adult lung (23) . Recent studies, however, have also highlighted an important role of myofibroblasts during postnatal development of the mouse lung (56) . The stereological data on the mouse and the rat lung provided in the present study indicate that the postnatal development of the lipofibroblasts is not identical in these two species, but the overall time course as described by Kaplan et al. (23) is confirmed by our data. The amount of lipid bodies in the adult rodent lung shows a certain degree of phenotypic plasticity, as obese, diabetic rats contain a higher amount of lipid body-laden fibroblasts (11) . The investigation of five postnatal human lungs, however, again did not provide evidence for a role of lipofibroblasts in human lung development. Lipid bodies associated with interstitial alveolar cells were very rarely observed and belonged to cells that were morphologically different from fibroblasts and could rather be classified as leukocytes, which are known to contain lipid bodies (33) .
Taken together, our study confirms the presence of lipofibroblasts in the postnatal and adult rodent lung, but we did not find evidence for their presence in the lungs of other adult mammalian species or in the postnatal human lung. If lipofibroblasts play a significant role in lung regeneration in general, it is likely to be present only in the rodent lung. These results and considerations may offer an explanation why lipofibroblast-dependent successful regenerative approaches to treat emphysema in the mouse may not be reproducible when tested in humans.
